MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today its financial results for the Company's second quarter ended June 30, 2008. The Company reported net income from continuing operations of $37.2 million (or $0.61 per share) for the three months ended June 30, 2008, compared with net income from continuing operations of $29.3 million (or $0.48 per share) for the second quarter of 2007.
